Plasma IL-6 and HPA-axis function in depression and anxiety in patients with cancer.

被引：0
|
作者：
Jehn, CF
Kühnhardt, DM
Possinger, K
Flath, B
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：737S / 737S
页数：1
相关论文
共 50 条
  • [41] Association of plasma IL-6 and soluble IL-6 receptor levels with the Asp358Ala polymorphism of the IL-6 receptor gene in schizophrenic patients
    Sasayama, Daimei
    Wakabayashi, Chisato
    Hori, Hiroaki
    Teraishi, Toshiya
    Hattori, Kotaro
    Ota, Miho
    Ishikawa, Masanori
    Arima, Kunimasa
    Higuchi, Teruhiko
    Amano, Naoji
    Kunugi, Hiroshi
    JOURNAL OF PSYCHIATRIC RESEARCH, 2011, 45 (11) : 1439 - 1444
  • [42] IL-6 levels decrease with SSRI treatment in patients with major depression
    Basterzi, AD
    Aydemir, Ç
    Kisa, C
    Aksaray, S
    Tuzer, V
    Yazici, K
    Göka, E
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2005, 20 (07) : 473 - 476
  • [43] Prevalence and associated factors of anxiety and depression in patients with metastatic gastrointestinal cancer.
    Han, Hye Sook
    Chung, Jung Hwa
    Kwon, Jihyun
    Lee, Ki Hyeong
    Kim, Seung Taik
    Ju, Gawon
    Lee, Ok-Jun
    Lee, Jin Yong
    Yun, Jieun
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [44] Targeting the IL-6/JAK/STAT3 signalling axis in cancer
    Daniel E. Johnson
    Rachel A. O'Keefe
    Jennifer R. Grandis
    Nature Reviews Clinical Oncology, 2018, 15 : 234 - 248
  • [45] Targeting the IL-6/JAK/STAT3 signalling axis in cancer
    Johnson, Daniel E.
    O'Keefe, Rachel A.
    Grandis, Jennifer R.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2018, 15 (04) : 234 - 248
  • [46] Polymorphisms in the gene encoding the neuropeptide galanin are associated with HPA-axis dysregulation and symptome severity in major-depressive- and anxiety-disorder patients
    Unschuld, P. G.
    Ising, M.
    Roeske, D.
    Erhardt, A.
    Specht, M.
    Ripke, S.
    Uhr, M.
    Kloiber, S.
    Mueller-Myhsok, B.
    Holsboer, F.
    Binder, E. B.
    PHARMACOPSYCHIATRY, 2009, 42 (05) : 244 - 244
  • [47] Using interleukin-6 and hypothalamus-pituitary-adrenal (HPA) axis function as potential diagnostic markers in the assessment of depression in patients with advanced breast cancer
    Jehn, CF
    Kuehnhardt, D
    Bartholomae, A
    Pfeiffer, S
    Schmid, P
    Possinger, K
    Flath, BC
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S276 - S277
  • [48] Prenatal interleukin-6 (IL-6) exposure results in hypertension and increased hypothalamo-pituitary-adrenal (HPA) axis activity
    Samuelsson, AM
    Ploj, K
    Larsson, BM
    Dahlgren, J
    Holmäng, A
    PEDIATRIC RESEARCH, 2003, 53 (06) : 34A - 34A
  • [49] Evaluation of clinical usefulness of VEGF, IL-1a and IL-6 as a tumor marker for cervical cancer.
    Park, WH
    Lee, MJ
    Lee, KO
    CLINICAL CHEMISTRY, 2000, 46 (06) : A158 - A158
  • [50] Depression, anxiety and delirium are associated with thyroid axis function in brain tumor patients
    Labakhua, T.
    Janashia, T.
    Gedevanishvili, G.
    Tkemaladze, T.
    Abzianidze, E.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S353 - S353
12345